ETOPOSIDE
Generic: ETOPOSIDE
Fresenius Kabi USAManufacturer
INTRAVENOUSRoute
ETOPOSIDEActive Substance
1998-09-30Original Approval
ETOPOSIDE is FDA application ANDA074983, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
8,393 reports
2
FEBRILE NEUTROPENIA
7,746 reports
3
NEUTROPENIA
5,069 reports
4
DRUG INEFFECTIVE
4,759 reports
5
DISEASE PROGRESSION
4,532 reports
6
THROMBOCYTOPENIA
4,140 reports
7
PYREXIA
3,405 reports
8
ANAEMIA
3,353 reports
9
SEPSIS
2,998 reports
10
PRODUCT USE IN UNAPPROVED INDICATION
2,973 reports